Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can prebiotic sodas curb your appetite? new study investigates

NCT ID NCT07362563

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 16, 2026 · Updated 4 times

Summary

This pilot study is testing whether drinking prebiotic sodas can increase hormones that make you feel full, compared to a regular soda. Fifteen healthy adults will drink different sodas and have their blood and stomach emptying measured over two hours. The goal is to see if the added fiber in these sodas has a noticeable effect on appetite and digestion.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
prebiotic soda
What this could lead to
If successful, this could show that prebiotic sodas help manage appetite and blood sugar, pointing toward a simple dietary aid for weight control.
What could go wrong
This is a very small pilot study (15 people) looking at short-term effects only. Results may not apply to the general population or lead to long-term benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Started

Feb 2026

Finished

May 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-60 years, inclusive. * BMI between 18.0 and 30.0 kg/m2. * Stable weight in the last 3 months (+/-5kg). * Willing to abstain from unusual strenuous exercise, consuming alcoholic drinks and from taking fiber supplements for 24 hours before study days. * Willing to refrain from smoking tobacco or e-cigarettes, and using marijuana in any form for 12h before and during study visits. * Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator. * Subjects must be eligible to receive income in Canada and be covered by a health insurance plan such as Ontario Health Insurance Plan (OHIP). Exclusion Criteria: * Self-reported pregnant or breastfeeding women. * Subjects with a history of severe food allergies or an allergy to acetaminophen. * Known history of diabetes, any gastrointestinal disorder that alters the absorption of nutrients, liver disease, or the presence of any health condition, illness or drug use that increases risk to the subject or to others or may affect the results, as judged by the Qualified Investigator (QI). * Subjects who are currently or in the last 2 months have been on oral or injectable GLP-1 receptor agonist (RA) medications. * Subjects who consume more than 14 alcoholic drinks per week, or more than 5 alcoholic drinks on any one occasion. * Subjects who have been on antibiotic therapy in the last 2 months. * Subjects taking the blood thinning drug warfarin. * Subjects who are habitual users of the following supplements in the past 30 days: berberine, curcumin, cinnamon, resveratrol, and gardenia. * Subjects which have undergone major surgery in the last 3 months. * Unwillingness or inability to comply with experimental procedures and to follow Inquis safety guidelines. * Subject is currently participating or recently (within 30 days of screening) participated in a clinical trial involving long-term exposure (greater than 24 hours) to an investigational drug, nutritional supplement, or lifestyle modification.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Satiety in healthy volunteers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inquis Clinical Research

    Toronto, Ontario, M5C 2N8, Canada